Welcome readers, we are currently gathering a database and you will be able to enjoy PlexPage starting June 1st fully. In the meantime, please check out the web.plex.page and scholar.plex.page.

Organ Transplantation

Summarized by Plex Health
Last Updated: 02 May 2022
medical gases: a novel strategy for attenuating ischemia-reperfusion injury in organ transplantation? "medical gases: a novel strategy for attenuating ischemia-reperfusion injury in organ transplantation?", by Siriussawakul A, Chen LI, Lang JD. fig1: Preemptive treatment with inhaled nitric oxide, carbon monoxide and hydrogen sulfide can attenuate ischemia-reperfusion injury via modulation of a myriad of inflammatory, cellular and vascular mechanisms. GTP: guanosine triphosphate, GC: guanylate cyclase, cGMP: cyclic...

Organ transplant receivers have a high risk of developing 32 various types of cancer, according to a new research. Transplant recipients are known to be at a higher risk for developing cancer than the general population. Past studies of cancer risk in transplant recipients concentrated primarily on those that got kidney transplants. Smoking-related disease is usually the reason for a lung transplant, and lung cancer normally arises in the continuing to be infected lung instead of the transplanted one. The risk of liver cancer was elevated only among liver recipients. While transplantation is a life-saving therapy for patients with end-stage organ disease, it also puts recipients at an increased risk for developing cancer, in part since of medications provided to protect against and suppress the immune system being rejected of the organ, Engels says. The cancer risk among transplant recipients appears like that of people with HIV infection, whose risk is elevated for infection-related cancers due to immunosuppression. The FOA represents a merger and growth of two previous research consortia: the Clinical Trials in Organ Transplantation and the Clinical Trials in Organ Transplantation in Children. The CTOT-CA will support a participating, multi-institutional consortium for conducting interventional trials or observational scientific studies in pediatric and/or adult prospects for or receivers of allogeneic organ, vascularized composite tissue, or cellular replacement transplants requiring long-lasting immunosuppression under the present criterion of treatment. Generally, a tube is threaded through capillary until it gets to the heart and a small piece of heart tissue is eliminated and fetched for analysis. In cases where female patients have received body organs from male donors, it has been feasible to spot the visibility of DNA from the Y chromosome, but female patients that have received male organs make up less than a quarter of transplant patients, so a global method represents a considerable advance. Donor DNA was identified by looking for solitary nucleotide polymorphisms that the patient was homozygous for yet that the donor was either heterozygous, or homozygous with a different version. The research found that above a threshold of two percent donor DNA in the blood, there was an 80 percent real positive rate for tissue rejection, together with a 15 percent false positive rate.

* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions

** If you believe that content on the Plex is summarised improperly, please, contact us, and we will get rid of it quickly; please, send an email with a brief explanation.

*** If you want us to remove all links leading to your domain from Plex.page and never use your website as a source of the "Online Knowledge", please contact us using a corporate email and we will remove everything in 10 business days.


Plex Page is a Biology & Health Sciences "Online Knowledge Base," where a machine summarizes all the summaries.